ArticleSpringerPlus2015

Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine.

Takayo Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.